Fundraising
We support the management from the strategic structuring in early phases of the process, then throughout the roadshow and until the final phases of negotiations
Seed to Serie C
Venture/Growth Capital &
Private Equity
Cross border transactions
US, European or Asian investors
Large network of investors
400+ HealthCare investors
(VCs, PEs, Family Offices, Corporate...)
Recent transactions
Fundraising
€1.5M in 2026
Biotech company developing innovative peptide therapies for cardio-renal diseases
Fundraising
€1.2M in 2026
Innovative liquid biopsy diagnostics for cancer monitoring and early relapse detection
Fundraising
€1.5M in 2025
Developer of innovative immunotherapies designed to enhance antitumor immune responses
pre-Series A
€2M in 2025
Developer of innovative molecules to treat severe disease involving regulated necrosis
Series A
£8.7m in 2022
Designer of medical biomaterials based on collagen from marine sources
Series A
€9M in 2018
Medtech company developing an innovative treatment for glioblastoma